GA-Pyridine Monoclonal Antibody

<strong>GA-Pyridine Monoclonal Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2017089_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 uL_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20℃_x000D_ <strong>Keywords:</strong> N/A_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Kobashigawa Y, Ohara T, Morita K, Toyota Y, Nakamura T, Kotani S, Arimori T, Yamauchi S, Liu C, Kitazaki M, Wakeyama-Miyazaki Y, Suwa Y, Uchida-Kamekura M, Fukuda N, Sato T, Nakajima M, Takagi J, Yamagata Y, Morioka H. Molecular recognition of a single-chain Fv antibody specific for GA-pyridine, an advanced glycation end-product (AGE), elucidated using biophysical techniques and synthetic antigen analogues J Biochem. 2021 Oct 12;170(3):379-387._x000D_ 2: Greven WL, Waanders F, Nagai R, van den Heuvel MC, Navis G, van Goor H. Mesangial accumulation of GA-pyridine, a novel glycolaldehyde-derived AGE, in human renal disease Kidney Int. 2005 Aug;68(2):595-602._x000D_ 3: Nagai R, Hayashi CM, Xia L, Takeya M, Horiuchi S. Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins J Biol Chem. 2002 Dec 13;277(50):48905-12._x000D_ 4: Fukuda N, Noi K, Weng L, Kobashigawa Y, Miyazaki H, Wakeyama Y, Takaki M, Nakahara Y, Tatsuno Y, Uchida-Kamekura M, Suwa Y, Sato T, Ichikawa-Tomikawa N, Nomizu M, Fujiwara Y, Ohsaka F, Saitoh T, Maenaka K, Kumeta H, Shinya S, Kojima C, Ogura T, Morioka H. Production of Single-Chain Fv Antibodies Specific for GA-Pyridine, an Advanced Glycation End-Product (AGE), with Reduced Inter-Domain Motion Molecules. 2017 Oct 10;22(10):1695._x000D_ 5: Murakami Y, Fujino T, Hasegawa T, Kurachi R, Miura A, Daikoh T, Usui T, Hayase F, Watanabe H. Receptor for advanced glycation end products (RAGE)-mediated cytotoxicity of 3-hydroxypyridinium derivatives Biosci Biotechnol Biochem. 2018 Feb;82(2):312-319._x000D_ 6: Hirose J, Yamabe S, Takada K, Okamoto N, Nagai R, Mizuta H. Immunohistochemical distribution of advanced glycation end products (AGEs) in human osteoarthritic cartilage Acta Histochem. 2011 Oct;113(6):613-8._x000D_ 7: Muraoka T, Siti N, Ueno K. C-O and C-C bond cleavage of α,β-unsaturated esters with the assistance of a gallane(pyridyl)iron complex Dalton Trans. 2021 Nov 16;50(44):15996-16002._x000D_ 8: Mera K, Takeo K, Izumi M, Maruyama T, Nagai R, Otagiri M. Effect of reactive-aldehydes on the modification and dysfunction of human serum albumin J Pharm Sci. 2010 Mar;99(3):1614-25._x000D_ 9: Liu C, Kobashigawa Y, Yamauchi S, Fukuda N, Sato T, Masuda T, Ohtsuki S, Morioka H. Convenient method of producing cyclic single-chain Fv antibodies by split-intein-mediated protein ligation and chaperone co-expression J Biochem. 2020 Sep 1;168(3):257-263._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/29804507">10: Murakami Y, Fujino T, Kurachi R, Hasegawa T, Usui T, Hayase F, Watanabe H. Identification of pyridinoline, a collagen crosslink, as a novel intrinsic ligand for the receptor for advanced glycation end-products (RAGE) Biosci Biotechnol Biochem. 2018 Sep;82(9):1508-1514. </a>_x000D_ _x000D_ <strong>Products Related to GA-Pyridine Monoclonal Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>